S
Star Therapeutics
Biotech & Life Sciences · South San Francisco, United States · Founded 2018
Developing life-changing therapies for rare diseases MoreLess
Star Therapeutics focuses on developing life-changing therapies for rare diseases, addressing the needs of millions of patients worldwide. Operating in the biopharmaceutical sector, the company targets approximately 7,000 rare diseases, of which only about 650 have FDA-approved treatments. Star Therapeutics employs a business model centered around the development of first-in-class antibody therapeutics built on novel biology. The company generates revenue through the research, development, and eventual commercialization of these therapies. Star Therapeutics serves patients with rare diseases, healthcare providers, and the broader medical community. The company is committed to innovation and collaboration, fostering a culture of creative and forward-thinking professionals. Keywords: rare diseases, antibody therapeutics, biopharmaceutical, FDA-approved, novel biology, life-changing therapies, innovation, collaboration, healthcare, commercialization.
Company overview
Star Therapeutics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2018
- Headquarters
- South San Francisco, United States
- Employees
- 59
- Open positions
- 1
- Dealroom signal
- 86.1
- Investment activity
- 1 companies · latest May 2026
- Capital deployed
- $0
- Preferred round
- CORPORATE SPINOUT
Valuation & funding
Star Therapeutics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Sep 2025 | $125M | $500M | Undisclosed | ↗ |
| SERIES COther financing | Sep 2023 | $90M | $500M | New Leaf Venture Partners · OrbiMed · Redmile Group · Westlake Village BioPartners | ↗ |
| LATE VCOther financing | Feb 2022 | $100M | $400M | New Leaf Venture Partners · OrbiMed · Redmile Group · RA Capital Management | ↗ |
| SPINOUTOther financing | Jan 2018 | $0 | — | Electra Therapeutics | — |
Growth signals
Star Therapeutics website traffic
Latest recorded traffic for Star Therapeutics is 3.7K monthly website visits, up 94.7% over the last three months. Star Therapeutics's team grew 11.3% over the past year.
Hiring
Open positions at Star Therapeutics
Current openings linked to this company in Dealroom.
Comparisons
Star Therapeutics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Star Therapeutics investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
Star Therapeutics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Star Therapeutics has talent and traffic
team presence
In the news
Latest news about Star Therapeutics
Recent press, funding announcements, and product moves mentioning Star Therapeutics — open to read from the original sources.
Market sentiment
What the market is saying about Star Therapeutics
An AI-synthesized read of the highest-engagement posts about Star Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Star Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.